About Lygature
A non profit organization that brings academia industry and society together. All Lygature partners have access to expertise on drug development, data management, medical technology, global public health, patient engagement, financial and legal support.
Work within different themes:
- Data Infrastructure: enabling health research through efficient data infrastructure
- Global health: solutions to medical needs by partnering, acquiring funds, sharing risks & resources
- Health law, privacy & ethics: sharing data involves legal & ethical issues
- Regulated innovation: finding an effective system that is ready for tech and science innovations
- Strategic asset sharing: combining resources to surpass what individual organizations can achieve
- Flagship Alliances: supporting initiatives like Oncode Institute & Health-RI
Mission: So deliver breakthrough innovations in medical technology and drug development that address unmet medical needs by providing partnership management.
Vision: Solving the complex global health challenges requires the collaboration of academia, industry, government and society. A skilled neutral enabler, for trust, is essential for success of large multi-stakeholder research and development partnerships to address unmet medical needs.
Collaborations with GHH-partners
- Amsterdam UMC: partner in EPND. Research and publishing EPND data, running EPND. To be able to detect early onset of neurodegenerative diseases.
- UMC Utrecht: MOMENTUM (2020) coordination (study for MR-Guided adaptive therapy-magnetic resonance radiation therapy), ILLUMINATE coordination (aims to transform cancer treatment by enhancing metabolic imaging)
- Erasmus MC: supports CONTRAST program – multistakeholder effort to develop innovative stroke treatments
- Radboud umc: CONTRAST 2.0 (2024), TI Pharma project to clinic: trial malaria vaccine (2017)
- LUMC: TI Pharma project, partner CONTRAST 2.0
- UMCG: partner CONTRAST 2.0
- Health~Holland: Health-RI partner- accelerating development of personalized medicine & health solutions by connecting research data infrastructures.
Overview of characteristics
Active in countries
Uganda, Cote d’Ivoire, Kenya, Tanzania, Senegal: PZQ ADOPT programme, closing treatment gap for young children to eliminate schistosomiasis. Part of ADOPT program- large scale delivery of the treatment for preschool-aged children.
Uganda, Tanzania, South Africa, Vietnam, Philippines, Moldova, Brazil: UNITE4TB trial sites against tbc. Academia & industry united innovation and treatment
CoP (Community of Practice)
- Community of Practice 1: Strengthening Health Systems
- Community of Practice 2: Pandemic Preparedness
- Community of Practice 3: Climate change & Health
Themes and subthemes within CoP
- Access, diagnostics & surveillance on neglected tropical diseases (NTD’s). Fits CoP1 because treatment implementation, fits CoP2 because strengthens drug-access, regulatory & delivery mechanisms that are re-usable for future outbreaks. Fits CoP3 because spreading of NTDs links to climate/globalization.
- TB & AMR regimen platforms like UNITE4TB, preparedness for more outbreaks.
- FAIR data & access (health RI)
Organization Type:
NGO
Available resources
- Knowledge & expertise: experience with partnership management, data governance, regulatory innovation, access-to-medicine-strategies, TBC, oncology and data infrastructure. (Pediatric Praziquantel Consortium, UNITE4TB, AI4NTD, Health RI)
- Networks: extensive links with academia, industry, governments, NGO’s (WHO, Cermel, KEMRI, via Pediatric Praziquantel Consortium, UNITE4TB, Health RI)
- Influence/agenda setting: ability to convene public/private stakeholders & set partnership standards/frameworks (via Partnership Framework methodology and steering group role in Health RI)
- Financial leverage/access to funds: participant & co-manager in large EU-funded programmes (IMI/IHI, Horizon Europe, Health~Holland)
- Coordination & platform capability: programme management, communication and legal-financial infrastructure supporting multi-country consortia (UNITE4TB, AI4NTD, Health-RI)